TCL Archive Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure November 26, 2014
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006